BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Nordic AML Group - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nordic AML Group
X-ORIGINAL-URL:https://www.namlg.org
X-WR-CALDESC:Events for Nordic AML Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240924T150000
DTEND;TZID=Europe/Paris:20240924T163000
DTSTAMP:20260526T053702
CREATED:20240804T181813Z
LAST-MODIFIED:20240829T085437Z
UID:10000014-1727190000-1727195400@www.namlg.org
SUMMARY:Webinar - Azacitidine-Venetoclax: latest clinical updates
DESCRIPTION:The NAMLG’s Educational Working Group is hosting a webinar on September 24\, 2024\, from 15:00 to 16:30 CEST. The webinar will provide the latest insights on using Aza-Ven in AML treatment including discussions from a Nordic perspective. Topics will include its application as a first-line treatment\, dosing optimizations\, and strategies for maintenance therapy. \nYou can find the program here. \nThere is no registration required as the webinar will be sent via Zoom\, see the program for details and passcode. \nThe webinar is supported by AbbVie and the KG Jebsen Centre for Myeloid Blood Cancer at the University of Bergen.
URL:https://www.namlg.org/event/webinar-azacitidine-venetoclax-latest-clinical-updates/
END:VEVENT
END:VCALENDAR